LithopsBio
Cloud drug discovery — powered by scalable human models and AI.
We’re building the platform to help you close that gap
— accurately and predictably.
EARLY TESTING ON HUMANS IS BAD — SO WE DONT
Develop drugs using
mice, & generic human cells
Give drugs to people
expecting positive outcome
MICEare notHUMANS
99% of genes are sharedBUT60% difference in sequence50% difference in regulation
PEOPLEareINDIVIDUALS
Person-to-personthe human genomediffers at2-3 million sites
BRAINSareCOMPLEX
~86 Billion brain cells>100 Trillion connections>3,000 cell types3D organisation
Sometimes the GAP is too large to bridge
BUT
WHAT IF early testing on humans was OK ...
It can be — with lab grown miniature human organs | organoids
COLLECT
Patients' own
skin cells
GROW
Patient-specific
brain organoid
DEVELOP
Patient drugs
that work
Organoids have 3D structure and cell diversity of human organs.
This is critical for replicating the biological and pathological processes that emerge from this complexity.
DRUG DISCOVERY WITH LITHOPSBIO
Access Tools on Your Terms.
Make Data-Driven Decisions You Can Rely On.
Our cloud lab platform uses patient-relevant models to enhance the accuracy and predictability of your pre-clinical drug development — scaling your capabilities while safeguarding your intellectual property.